NCT01137292 Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection Status COMPLETED Phase N/A
NCT01135511 A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease Status COMPLETED Phase PHASE2
NCT01133210 Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I) Status COMPLETED Phase PHASE1
NCT01132690 A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Status COMPLETED Phase PHASE4
NCT01129258 Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01128712 Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin Status TERMINATED Phase PHASE4
NCT01128439 Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease Status COMPLETED Phase N/A
NCT01128426 Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers Status COMPLETED Phase N/A
NCT01127906 Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin Status COMPLETED Phase PHASE1
NCT01127893 Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis Status TERMINATED Phase PHASE3
NCT01127308 A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038) Status COMPLETED Phase PHASE1
NCT01126866 Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy Status TERMINATED Phase PHASE2
NCT01125904 A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT01125631 Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01122680 Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma Status COMPLETED Phase PHASE2
NCT01122615 Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) Status COMPLETED Phase PHASE1
NCT01122498 A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears Status TERMINATED Phase PHASE1
NCT01121588 Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK) Status TERMINATED Phase PHASE1
NCT01121575 A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer Status COMPLETED Phase PHASE1